(E)-6-((tert-butoxycarbonyl)amino)-6,6-dimethylhex-2-en-1-ol | 1353722-62-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (E)-6-((tert-butoxycarbonyl)amino)-6,6-dimethylhex-2-en-1-ol
• 英文别名: (E)-tert-butyl 7-hydroxy-2-methylhept-5-en-2-ylcarbamate；tert-butyl N-[(E)-7-hydroxy-2-methylhept-5-en-2-yl]carbamate
• CAS: 1353722-62-9
• 化学式: C₁₃H₂₅NO₃
• 分子量: 243.346
• InChiKey: DZFWISKWOCHCEO-SOFGYWHQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.77
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-6-((tert-butoxycarbonyl)amino)-6,6-dimethylhex-2-en-1-ol 在 盐酸 、 四溴化碳 、 碘 、 magnesium oxide 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 、 1,2-二氯乙烷 为溶剂， 反应 6.83h， 生成 (E)-N-(7-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methylhept-5-en-2-yl)-3-methoxybenzenesulfonamide
  参考文献：
  名称：

  Discovery of Highly Potent Human Deoxyuridine Triphosphatase Inhibitors Based on the Conformation Restriction Strategy

  摘要：

  Human deoxyuridine triphosphatase (dUTPase) inhibition is a promising approach to enhance the efficacy of thymidylate synthase (TS) inhibitor based chemotherapy. In this study, we describe the discovery of a novel class of human dUTPase inhibitors based on the conformation restriction strategy. On the basis of the X-ray cocrystal structure of dUTPase and its inhibitor compound 7, we designed and synthesized two conformation restricted analogues, i.e., compounds 8 and 9. These compounds exhibited increased in vitro potency compared with the parent compound 7. Further structure activity relationship (SAR) studies identified a compound 43 with the highest in vitro potency (IC50 = 39 nM, EC50 = 66 nM). Furthermore, compound 43 had a favorable oral PK profile and exhibited potent antitumor activity in combination with 5-fluorouracil (5-FU) in the MX-1 breast cancer xenograft model. These results suggested that a dUTPase inhibitor may have potential for clinical usage.

  DOI：

  10.1021/jm300416h
• 作为产物：
  描述：

  tert-butyl 5-hydroxy-2,2-dimethylpyrrolidine-1-carboxylate 在 二异丁基氢化铝 作用下， 以 四氢呋喃 、 甲苯 为溶剂， 反应 20.0h， 生成 (E)-6-((tert-butoxycarbonyl)amino)-6,6-dimethylhex-2-en-1-ol
  参考文献：
  名称：

  Discovery of Highly Potent Human Deoxyuridine Triphosphatase Inhibitors Based on the Conformation Restriction Strategy

  摘要：

  Human deoxyuridine triphosphatase (dUTPase) inhibition is a promising approach to enhance the efficacy of thymidylate synthase (TS) inhibitor based chemotherapy. In this study, we describe the discovery of a novel class of human dUTPase inhibitors based on the conformation restriction strategy. On the basis of the X-ray cocrystal structure of dUTPase and its inhibitor compound 7, we designed and synthesized two conformation restricted analogues, i.e., compounds 8 and 9. These compounds exhibited increased in vitro potency compared with the parent compound 7. Further structure activity relationship (SAR) studies identified a compound 43 with the highest in vitro potency (IC50 = 39 nM, EC50 = 66 nM). Furthermore, compound 43 had a favorable oral PK profile and exhibited potent antitumor activity in combination with 5-fluorouracil (5-FU) in the MX-1 breast cancer xenograft model. These results suggested that a dUTPase inhibitor may have potential for clinical usage.

  DOI：

  10.1021/jm300416h

文献信息

• Enantioselective Synthesis of Pyrrolidine-, Piperidine-, and Azepane-Type <i>N</i>-Heterocycles with α-Alkenyl Substitution: The CpRu-Catalyzed Dehydrative Intramolecular <i>N</i>-Allylation Approach
  作者：Tomoaki Seki、Shinji Tanaka、Masato Kitamura

  DOI：10.1021/ol203218d

  日期：2012.1.20

  acid derivatives [(R)- or (S)-Cl-Naph-PyCOOCH2CH═CH2] catalyzes asymmetric intramolecular dehydrative N-allylation of N-substituted ω-amino- and -aminocarbonyl allylic alcohols with a substrate/catalyst ratio of up to 2000 to give α-alkenyl pyrrolidine-, piperidine-, and azepane-type N-heterocycles with an enantiomer ratio of up to >99:1. The wide range of applicable N-substitutions, including Boc, Cbz

  阳离子CPRU复杂的手性吡啶甲酸衍生物[（的[R ）-或（小号）-Cl-的Naph-PyCOOCH 2 CH = CH 2 ]催化不对称分子内脱水Ñ的-allylation Ñ取代ω氨基-和氨基羰基烯丙基醇底物/催化剂比例最高为2000，可得到对映体比例最高> 99：1的α-烯基吡咯烷-，哌啶-和氮杂环庚烷型N-杂环。广泛适用的N取代基，包括Boc，Cbz，Ac，Bz，丙烯酰基，巴豆酰基，甲酰基和Ts，极大地促进了对天然产物合成的进一步控制。